CLINICAL_TRIALS trial_result · 2015-02-13

Clinical Trial Update: An Investigational Drug Study to Assess Weight Loss in Patients With Type 2 Diabetes Mellitus (0364-011)(TERMINATED) [Phase 3]

A Phase 3 investigational drug trial evaluating weight loss in patients with obesity and type 2 diabetes mellitus was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Merck Sharp & Dohme LLC | Conditions: Obesity Type 2 Diabetes Mellitus, Type 2 Diabetes Mellitus | Phase 3 | Status: TERMINATED